Background/objectives Pulmonary arterial hypertension is an important complication in
hemodynamically relevant atrial septal defects (ASD) and negatively affects outcome. This …

Background—Pulmonary arterial hypertension (PAH) may develop in patients with atrial
septal defects (ASD); however, little is known about associated risk factors and its evolution …

Conclusion Pulmonary hypertension can occur in the presence of an ASD, and might be
suspected by echocardiography. Currently, exercise echocardiography is not recommended …

Background The development or persistence of pulmonary arterial hypertension (PAH) after
atrial septal defect (ASD) closure at adult age is associated with a poor prognosis. The …

Objective Closure of atrial septal defects (ASD) prevents pulmonary hypertension, right heart
failure and thromboembolic stroke. The exact timing for ASD closure is controversial …

Background Patients with simple shunt lesions, such as atrial septal defect (ASD),
ventricular septal defect (VSD) and persistent arterial duct (PDA) remain at risk of …

Patients having atrial septal defect (ASD) with moderate and more importantly severe
pulmonary arterial hypertension (PAH) pose a clinical dilemma. Closing ASD in those with …

Pulmonary arterial hypertension (PAH) related to an atrial septal defect (ASD) poses a
challenge to transcatheter closure of an ASD (tcASD). We aimed to determine the predictors …

Background Atrial septal defect (ASD) is a common form of congenital heart disease.
Significant shunts may increase the risk of developing pulmonary hypertension (PH). We …

Secundum atrial septal defect (ASD) is the most common form of congenital heart disease in
adults. Surgical and transcatheter closures of ASD are widely accepted therapeutic …